Kite Pharma’s share price has dived after it emerged that a patient has died from cerebral oedema while being treated with its CAR-T therapy, KTE-C19. Investors were spooked by the news, fearing ...

Despite the kite’s struggle against the powerful winds pushing it upward, Maui was thrilled by the battle of wills—his ... After his death, the remnants of his adventures, including his ...